Accessibility Menu
 
MediPharm Labs logo

MediPharm Labs

(OTC) MEDIF

Current Price$0.05
Market Cap$20.07M
Since IPO (2018)-97%
5 Year-87%
1 Year-18%
1 Month-7%

MediPharm Labs Financials at a Glance

Market Cap

$20.07M

Revenue (TTM)

$45.11M

Net Income (TTM)

$8.27M

EPS (TTM)

$-0.01

P/E Ratio

-3.36

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Price

$0.05

Volume

12,816

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.04 - $0.08

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MediPharm Labs

Industry

Pharmaceuticals

Employees

127

CEO

David A. Pidduck, EMBA

Headquarters

Barrie, ON L4N 2L1, CA

MEDIF Financials

Key Financial Metrics (TTM)

Gross Margin

31%

Operating Margin

-19%

Net Income Margin

-18%

Return on Equity

-21%

Return on Capital

-23%

Return on Assets

-18%

Earnings Yield

-29.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.07M

Shares Outstanding

420.75M

Volume

12.82K

Short Interest

0.00%

Avg. Volume

93.16K

Financials (TTM)

Gross Profit

$13.10M

Operating Income

$8.64M

EBITDA

$6.98M

Operating Cash Flow

$5.33M

Capital Expenditure

$99.92K

Free Cash Flow

$5.43M

Cash & ST Invst.

$10.80M

Total Debt

$200.84K

MediPharm Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$11.05M

-8.2%

Gross Profit

$3.76M

+4.1%

Gross Margin

34.05%

N/A

Market Cap

$20.07M

N/A

Market Cap/Employee

$120.90K

N/A

Employees

166

N/A

Net Income

$1.97M

-13.9%

EBITDA

$1.47M

-28.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.60M

-7.8%

Accounts Receivable

$7.52M

+0.1%

Inventory

$8.01M

-8.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$200.84K

-40.4%

Return on Assets

-18.07%

N/A

Return on Invested Capital

-23.48%

N/A

Free Cash Flow

$474.61K

+142.7%

Operating Cash Flow

$474.61K

+144.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GBLPGlobal Pharmatech, Inc.
$0.05+0.00%
VYYRFVoyageur Pharmaceuticals Ltd.
$0.09+0.00%
RVXCFResverlogix Corp.
$0.08+0.00%
AVCNFAvicanna Inc.
$0.12+4.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.37+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.81+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$50.66+0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.40-0.01%

Questions About MEDIF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.